Complex Lemierre syndrome with multisystemic abscesses.

Détails

Ressource 1Télécharger: 37085282_BIB_08831342902A.pdf (828.13 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_08831342902A
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Complex Lemierre syndrome with multisystemic abscesses.
Périodique
BMJ case reports
Auteur⸱e⸱s
Bourgeaud J., Delabays B., Van den Bogaart L., Ratano D.
ISSN
1757-790X (Electronic)
ISSN-L
1757-790X
Statut éditorial
Publié
Date de publication
21/04/2023
Peer-reviewed
Oui
Volume
16
Numéro
4
Pages
e254638
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: epublish
Résumé
We present here the challenging case of severe Lemierre syndrome in a healthy woman in her late twenties, whose clinical presentation was characterised by lung abscesses and disseminated systemic abscesses in the brain, the abdomen and the soft-tissues, as a likely consequence of a patent foramen ovale. Blood cultures were positive for Fusobacterium necrophorum and a right lingual vein thrombosis was detected at a late stage when the patient developed a septic shock. Initial antimicrobial therapy with metronidazole and ceftriaxone was modified to meropenem due to progressive worsening. The patient underwent laparoscopy and neurosurgical drainage of a cerebral abscess. She spent many days in the intensive care unit and recovered fully after 6 weeks on meropenem therapy. Although considered rare, the incidence of Lemierre syndrome, a potentially life-threatening condition, is increasing. The clinician should promptly recognise and treat it while being aware of its potential atypical presentations.
Mots-clé
Female, Humans, Lemierre Syndrome/diagnosis, Lemierre Syndrome/drug therapy, Lemierre Syndrome/microbiology, Meropenem/therapeutic use, Brain Abscess/diagnostic imaging, Brain Abscess/drug therapy, Ceftriaxone/therapeutic use, Metronidazole/therapeutic use, Fusobacterium necrophorum, Anti-Bacterial Agents/therapeutic use, Fusobacterium Infections/complications, Fusobacterium Infections/diagnosis, Fusobacterium Infections/drug therapy, Ear, nose and throat/otolaryngology, Infectious diseases, Intensive care, Surgery
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/05/2023 9:50
Dernière modification de la notice
09/08/2024 14:55
Données d'usage